McKesson (NYSE:MCK) traded today at a new 52-week high of $242.30. Approximately 611,000 shares have changed hands today, as compared to an average 30-day volume of 1 million shares.
There is potential upside of 1.6% for shares of McKesson based on a current price of $242.16 and an average consensus analyst price target of $245.92. The stock should discover initial support at its 50-day moving average (MA) of $226.87 and subsequent support at its 200-day MA of $210.63.
McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
In the past 52 weeks, shares of McKesson have traded between a low of $177.73 and a high of $242.30 and are now at $242.16, which is 36% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.3% while the 200-day MA has risen 0.5%.